1. A Report from the 2013 International Symposium. Issue 5 (May 2015) Authors: Grant, E.J.; Ozasa, K.; Ban, N.; de González, A. Berrington; Cologne, J.; Cullings, H.M.; Doi, K.; Furukawa, K.; Imaoka, T.; Kodama, K.; Nakamura, N.; Niwa, O.; Preston, D.L.; Rajaraman, P.; Sadakane, A.; Saigusa, S.; Sakata, R.; Sobue, T.; Sugiyama, H.; Ullrich, R. Journal: Health physics Issue: Volume 108:Issue 5(2015:May) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Report from the 2013 International Symposium: The Evaluation of the Effects of Low-dose Radiation Exposure in the Life Span Study of Atomic Bomb Survivors and Other Similar Studies. Issue 5 (May 2015) Authors: Grant, E.J.; Ozasa, K.; Ban, N.; de González, A. Berrington; Cologne, J.; Cullings, H.M.; Doi, K.; Furukawa, K.; Imaoka, T.; Kodama, K.; Nakamura, N.; Niwa, O.; Preston, D.L.; Rajaraman, P.; Sadakane, A.; Saigusa, S.; Sakata, R.; Sobue, T.; Sugiyama, H.; Ullrich, R. Journal: Health physics Issue: Volume 108:Issue 5(2015:May) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open‐label, phase III, non‐inferiority study. Issue 10 (20th August 2015) Authors: Araki, E.; Inagaki, N.; Tanizawa, Y.; Oura, T.; Takeuchi, M.; Imaoka, T. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 10(2015:Oct.) Page Start: 994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide is non‐inferior to once‐daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26‐week randomized phase III study. Issue 10 (20th August 2015) Authors: Miyagawa, J.; Odawara, M.; Takamura, T.; Iwamoto, N.; Takita, Y.; Imaoka, T. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 10(2015:Oct.) Page Start: 974 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once‐daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study. Issue 3 (8th January 2016) Authors: Odawara, M.; Miyagawa, J.; Iwamoto, N.; Takita, Y.; Imaoka, T.; Takamura, T. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 3(2016) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗